This is also when you should be tracking your progress systematically
Ferrari F, Moretti A, Villa RF (2022) Incretin-based drugs as potential therapy for neurodegenerative diseases: current status and perspectives
In these cases, sterile vials, airtight sealing, and insulation from light are critical
The evidence obtained in multiple randomized clinical trials demonstrates that GLP1RAs are effective for the treatment of type 2 diabetes, obesity, and dyslipidemia
Its approach combines: Psychology-based daily lessons and mindset tools grounded in behavioral science Coaching and accountability support Food, weight, and habit tracking in a single app Access to licensed clinicians through the Noom Med program Multiple medical pathways, including full-dose GLP-1s, microdose GLP-1s, and oral weight-loss medications Ongoing guidance for side-effect management, appetite changes, and long-term habit maintenance Within Noom Med, prescription optionsincluding injectables, oral medications, and microdose alternativesare integrated directly into the behavior-change program
